Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
12 aug 2016 - 07:00
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug Announces Changes to the Supervisory Board and Executive Management
Bericht
Probiodrug Announces Changes to the Supervisory Board and Executive Management
HALLE (SAALE), Germany, 12 August 2016 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), today announced updates to the Supervisory Board and Management Team.
Datum laatste update: 21 februari 2026